SGLT2 Inhibitors Associated With Better Survival in PAH

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

The possible benefit follows similar observations in diabetes, heart failure, and kidney disease, but the potential mechanism remains unknown.
Medscape Medical News